"(Reuters) - Concordia International Corp (Toronto:
CXR.TO -
News), a Canadian specialty pharmaceutical company, is discussing alternatives to a leveraged buyout that include divesting a minority stake to a private equity firm, people familiar with the matter said on Monday."
unless it needs the money urgently. If it does, that will be problem. What CXR needs is to sell part of it to get 1 b to pay the debt. That will make different.